Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00087425
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2004-07-08
Brief Title:
Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkins Lymphoma or Chronic Lymphocytic Leukemia
Sponsor:
National Institute on Aging NIA
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Lymphoma |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| stage IV small lymphocytic lymphoma | View |
| contiguous stage II adult diffuse small cleaved cell lymphoma | View |
| noncontiguous stage II adult diffuse small cleaved cell lymphoma | View |
| recurrent adult diffuse small cleaved cell lymphoma | View |
| stage III adult diffuse small cleaved cell lymphoma | View |
| stage IV adult diffuse small cleaved cell lymphoma | View |
| contiguous stage II grade 1 follicular lymphoma | View |
| noncontiguous stage II grade 1 follicular lymphoma | View |
| recurrent grade 1 follicular lymphoma | View |
| stage III grade 1 follicular lymphoma | View |
| stage IV grade 1 follicular lymphoma | View |
| contiguous stage II grade 2 follicular lymphoma | View |
| noncontiguous stage II grade 2 follicular lymphoma | View |
| recurrent grade 2 follicular lymphoma | View |
| stage III grade 2 follicular lymphoma | View |
| stage IV grade 2 follicular lymphoma | View |
| contiguous stage II marginal zone lymphoma | View |
| noncontiguous stage II marginal zone lymphoma | View |
| recurrent marginal zone lymphoma | View |
| stage III marginal zone lymphoma | View |
| stage IV marginal zone lymphoma | View |
| refractory chronic lymphocytic leukemia | View |
| Waldenström macroglobulinemia | View |
| contiguous stage II small lymphocytic lymphoma | View |
| noncontiguous stage II small lymphocytic lymphoma | View |
| recurrent small lymphocytic lymphoma | View |
| stage III small lymphocytic lymphoma | View |